|
US2021125651A1
|
|
Topological material for trapping charge and switching a ferromagnet
|
|
US2021114975A1
|
|
Therapeutic compound and methods
|
|
US2021118200A1
|
|
Systems and methods for training machine learning algorithms for inverse problems without fully sampled reference data
|
|
WO2021076545A1
|
|
Clec12a antibody fragment sequences and methods
|
|
US2021108172A1
|
|
Three dimensional hydrogel for culturing of cells
|
|
WO2021076627A1
|
|
Push-pull non-reciprocal phase shifting
|
|
US2021123126A1
|
|
MAGNETIC MATERIAL INCLUDING a"-Fe16(NxZ1-x)2 OR A MIXTURE OF a"-Fe16Z2 AND a"-Fe16N2, WHERE Z INCLUDES AT LEAST ONE OF C, B, OR O
|
|
US2021108188A1
|
|
Non-covalent systems and methods for dna editing
|
|
US2021111298A1
|
|
Photodetectors
|
|
WO2021072115A1
|
|
Crispr-mediated human genome editing with vectors
|
|
US2021111733A1
|
|
System and method for a super-resolution digital-to-analog converter based on redundant sensing
|
|
WO2021067928A1
|
|
Treating epilepsy and other neurological disorders by targeting therapy to the endopiriform nucleus
|
|
WO2021076342A2
|
|
Systems and methods for batch cultivation of non-transgenic heterogametes
|
|
WO2021062119A1
|
|
Nk engager compounds that bind viral antigens and methods of use
|
|
WO2021061832A1
|
|
Genetically-edited immune cells and methods of therapy
|
|
WO2021055342A1
|
|
Immunotherapy compounds and methods
|
|
US2021072229A1
|
|
Nanowire evaulation systems and methods for predicting behavior of hydrogels and microsystem application
|
|
US2021069111A1
|
|
Cationic block polymer micelles for delivery of biological agents
|
|
US2021063512A1
|
|
Systems and methods for utilizing periodic irradiation to enhance sensitivity of magnetic resonance detection
|
|
US2021060530A1
|
|
Solvent-free Extractive Separation
|
